Serial Number 79306375
Registration 6635130
700

Registration Progress

Application Filed
Dec 10, 2020
Under Examination
Approved for Publication
Nov 23, 2021
Published for Opposition
Nov 23, 2021
Registered
Feb 8, 2022

Trademark Image

Basic Information

Serial Number
79306375
Registration Number
6635130
Filing Date
December 10, 2020
Registration Date
February 8, 2022
Published for Opposition
November 23, 2021
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 8, 2022
Registration
Registered
Classes
044

Rights Holder

Takara Bio Inc.

99
Address
4-38, Nojihigashi 7-chome,
Kusatsu-shi Shiga 525-0058
JP

Ownership History

Otsuka Pharmaceutical Co., Ltd.

Original Applicant
03
JP

Otsuka Pharmaceutical Co., Ltd.

Owner at Publication
03
JP

Otsuka Pharmaceutical Co., Ltd.

Original Registrant
03
JP

Takara Bio Inc.

New Owner After Registration #1
99
JP

Application History

27 events
Date Code Type Description Documents
Apr 27, 2024 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Mar 13, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Aug 9, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 16, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 15, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 8, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 6, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 23, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 23, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 17, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 17, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 3, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 20, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 13, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 24, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 24, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 17, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 16, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 23, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 19, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 18, 2021 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Mar 11, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 044
Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells for medical purposes

Additional Information

Design Mark
The mark consists of a design of comprised of two blue, curved lines forming an arrow shape which points up and towards the left, above a red chevron shape made of numerous shaded red triangles and diamonds, which points down and towards the right.
Color Claim
The color blue and red are claimed as a feature of the mark.

Classification

International Classes
044